Fulgent Genetics FLGT Ratios (2015-2026)

NASDAQ FLGT
$19.93 +0.12 (+0.61%)
As of: Aug 27, 2026 · 3:59 PM EDT
Reported Financials

Fulgent Genetics Quarterly Ratios

Periods 45 quarters
Latest Jun 2026

Fulgent Genetics reported a gross margin of 30.07% and a net margin of -34.58% for the quarter ended Jun 2026. These financial ratios cover 45 quarters of results from Mar 2015 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Mar2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin
80.92%75.31%75.73%52.08%43.63%15.53%28.43%30.32%47.05%35.78%34.28%37.30%37.32%41.79%38.59%42.10%42.24%8,145.50%30.21%30.07%
EBT Margin
70.11%59.93%63.07%10.97%1.66%-40.03%-31.81%-21.66%8.10%-205.94%-21.98%-15.79%-25.83%-10.56%-15.96%-26.31%-8.93%-7,318.50%-36.52%-34.77%
EBIT Margin
69.90%59.94%63.05%10.21%0.33%20.33%-37.52%-29.18%0.25%-214.34%-33.80%-26.62%-23.81%-21.17%-26.95%-24.10%-18.26%-125.00%-48.67%-42.25%
EBITDA Margin
69.90%59.94%63.05%10.21%0.33%20.33%-37.52%-29.18%0.25%-214.34%-33.80%-26.62%-23.81%-21.17%-26.95%-24.10%-18.26%-125.00%-48.67%-42.25%
Operating Margin
69.90%59.94%63.05%10.21%0.33%20.33%-37.52%-29.18%0.25%-214.34%-33.80%-26.62%-23.81%-21.17%-26.95%-24.10%-18.26%-125.00%-48.67%-42.25%
Net Margin
53.64%41.20%47.95%8.82%1.27%-28.80%-23.18%-16.55%-15.48%-181.76%-20.88%-12.26%-20.42%-7.73%-15.69%-23.17%-7.86%-5,854.50%-34.90%-34.58%
FCF Margin
65.30%28.25%57.16%6.28%14.52%34.07%-15.02%-3.55%6.28%16.77%4.98%-12.19%-48.85%27.87%-12.45%-45.23%6.02%-20,780.75%2.66%-32.34%
Efficiency
Inventory AverageInventory Avg.
0.78M
Assets AverageAssets Avg.
1,127.26M1,241.69M1,372.15M1,463.63M1,433.72M1,395.92M1,381.41M1,365.67M1,356.49M1,296.86M1,232.61M1,231.06M1,233.00M1,226.86M1,212.85M1,202.79M1,207.20M1,214.04M1,184.95M1,122.80M
Invested CapitalInvested Cap.
15.11M15.14M15.00M15.00M15.00M15.00M15.00M
Asset Utilization RatioAsset Util.
0.920.800.690.630.560.450.280.240.220.220.230.240.230.230.240.250.260.200.200.21
Leverage & Solvency
Interest Coverage RatioInterest Cover
3.060.00M87.54-756.24-0.00M-403.38-0.00M-0.00M-548.21-31.25-0.00M-611.41
Debt Ratio
0.020.010.010.010.010.010.010.000.000.000.000.000.000.000.000.000.000.000.000.00
Times Interest Earned
3.060.00M87.54-756.24-0.00M-403.38-0.00M-0.00M-548.21-31.25-0.00M-611.41
Valuation
Enterprise Value
-462.31M-443.37M-578.29M-509.43M-566.71M-523.04M-500.01M-454.87M-464.67M-426.97M-308.99M-315.41M-216.62M-262.18M-324.73M-297.87M-380.93M-341.35M-281.96M-262.67M
Return Ratios
Return on SalesROS
0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.02%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.43%0.00%0.00%
Return on Capital EmployedROCE
76.62%59.48%49.65%39.28%27.49%17.75%0.41%-2.10%-2.12%-15.98%-16.64%-16.59%-18.02%-6.41%-6.27%-6.43%-6.26%-4.90%-6.41%-8.23%
Return on Invested CapitalROIC
0.11%0.08%0.08%0.06%0.04%0.03%0.00%0.00%-0.01%-0.08%
Return on AssetsROA
0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%